![Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions - The American Journal of Pathology Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions - The American Journal of Pathology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d4dee775-8333-42f7-98bb-745e264b649e/gr1_lrg.jpg)
Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions - The American Journal of Pathology
![PDF) Effectiveness of adalimumab for ambulatory ulcerative colitis patients after failure of infliximab treatment: A first "real-life" experience in primary gastroenterology centers in Italy PDF) Effectiveness of adalimumab for ambulatory ulcerative colitis patients after failure of infliximab treatment: A first "real-life" experience in primary gastroenterology centers in Italy](https://i1.rgstatic.net/publication/267273167_Effectiveness_of_adalimumab_for_ambulatory_ulcerative_colitis_patients_after_failure_of_infliximab_treatment_A_first_real-life_experience_in_primary_gastroenterology_centers_in_Italy/links/5452a3630cf2cf51647a47f2/largepreview.png)
PDF) Effectiveness of adalimumab for ambulatory ulcerative colitis patients after failure of infliximab treatment: A first "real-life" experience in primary gastroenterology centers in Italy
![Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand preparing a pen with a needle for a patient to inject themselves with Stock Photo - Alamy Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand preparing a pen with a needle for a patient to inject themselves with Stock Photo - Alamy](https://c8.alamy.com/comp/2AB3RWN/eindhoven-the-netherlands-12th-november-2019-humira-adalimumab-an-open-package-containing-a-pen-with-a-needle-for-a-patient-to-inject-themselves-2AB3RWN.jpg)
Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand preparing a pen with a needle for a patient to inject themselves with Stock Photo - Alamy
![CONSIGLI PENNA HUMIRA - FORUM SULLE MALATTIE REUMATICHE INFIAMMATORIE CRONICHE AUTOIMMUNI (MA.R.I.C.A.) DEL GRUPPO REUMAMICI CONSIGLI PENNA HUMIRA - FORUM SULLE MALATTIE REUMATICHE INFIAMMATORIE CRONICHE AUTOIMMUNI (MA.R.I.C.A.) DEL GRUPPO REUMAMICI](http://reumamici.virtualspace.it/forum/download/file.php?avatar=181_1360177282.jpg)
CONSIGLI PENNA HUMIRA - FORUM SULLE MALATTIE REUMATICHE INFIAMMATORIE CRONICHE AUTOIMMUNI (MA.R.I.C.A.) DEL GRUPPO REUMAMICI
![Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand holding a pen with a needle for a patient to inject themselves with to Stock Photo - Alamy Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand holding a pen with a needle for a patient to inject themselves with to Stock Photo - Alamy](https://c8.alamy.com/comp/2AB3RT7/eindhoven-the-netherlands-12th-november-2019-humira-adalimumab-a-male-hand-holding-a-pen-with-a-needle-for-a-patient-to-inject-themselves-with-to-2AB3RT7.jpg)
Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand holding a pen with a needle for a patient to inject themselves with to Stock Photo - Alamy
![One target, different effects: a comparison of distinct therapeutic antibodies against the same targets | Experimental & Molecular Medicine One target, different effects: a comparison of distinct therapeutic antibodies against the same targets | Experimental & Molecular Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.3858%2Femm.2011.43.10.063/MediaObjects/12276_2011_Article_BFemm201162_Fig1_HTML.jpg)